Literature DB >> 3335783

Motility of murine lymphocytes during transit through cell cycle. Analysis by a new in vitro assay.

S Ratner1, R K Jasti, G H Heppner.   

Abstract

The relationship between the basal (spontaneous) motility of murine lymphocytes and their position in the cell cycle was examined in a new collagen gel motility assay system. Concanavalin A-stimulated or control lymphocytes were allowed to locomote into slabs of type I collagen gel. The assay configuration permitted extraction of both total populations and locomotory subpopulations as viable, single-cell suspensions suitable for phenotypic and cell analysis. Concanavalin A stimulation resulted in a significant increase in the mean distance traveled by the leading cell front in 4 hr, from 23 microns (controls) to 67 microns. The estimated percentage of motile cells increased from 0.9 to 2.8%. Similar increases were observed after 18 hr of locomotion. The SIg+, Thy-1+, L3T4+, and Ly-2+ subsets exhibited equivalent increases in motility. Total populations and locomotory subpopulations were allowed to incorporate 5-bromo-2'-deoxyuridine, and their cell cycle profiles were compared by dual parameter anti-5-bromo-2'-deoxyuridine, propidium iodide fluorescence analysis. Total population and locomotory subpopulations did not differ significantly with respect to the ratio G0/G1:S, indicating that lymphocytes in these two phases exhibited approximately equal motility. Cells in late S and G2 + M were significantly less motile; locomotory subpopulations contained 60 to 75% fewer G2 + M cells than the total populations from which they were derived. Taken together, the results indicate that the concanavalin A-induced increase in motility commences before S phase and that motility diminishes shortly before or during G2 + M.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3335783

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

1.  Changes in gravity inhibit lymphocyte locomotion through type I collagen.

Authors:  N R Pellis; T J Goodwin; D Risin; B W McIntyre; R P Pizzini; D Cooper; T L Baker; G F Spaulding
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-05       Impact factor: 2.416

2.  Human T lymphocytes and T-cell lines as target cells for lymphocyte chemotaxis.

Authors:  C O Zachariae; K Kaltoft; K Thestrup-Pedersen
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

3.  Impairment of lymphocyte locomotion in the tumor microenvironment and the effect of systemic immunotherapy with liposome-encapsulated muramyl-tripeptide-phosphatidylethanolamine.

Authors:  D Risin; E S Kleinerman; Y Umezu; R P Pizzini; C M Balch; N R Pellis
Journal:  Cancer Immunol Immunother       Date:  1995-01       Impact factor: 6.968

4.  GTSE1 is a microtubule plus-end tracking protein that regulates EB1-dependent cell migration.

Authors:  Massimilano Scolz; Per O Widlund; Silvano Piazza; Debora Rosa Bublik; Simone Reber; Leticia Y Peche; Yari Ciani; Nina Hubner; Mayumi Isokane; Martin Monte; Jan Ellenberg; Anthony A Hyman; Claudio Schneider; Alexander W Bird
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.